Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) issued this Form 8-K on November 21, 2013, primarily to provide updated financial guidance for the full fiscal year 2013. The company reaffirmed its expectation for net income per diluted share to be at least $8.45. This guidance includes a net negative impact of $0.05 per share from various items, resulting in an adjusted net income per diluted share expectation of at least $8.40. Investors should note that this guidance excludes any investment gains or losses beyond those already recorded in the first nine months of 2013. The filing details specific adjustments such as net realized gains on investments, other-than-temporary impairment losses, debt extinguishment, tax benefits, and acquisition/integration costs. The company also included a standard safe harbor statement cautioning investors about the forward-looking nature of these statements and the risks and uncertainties that could affect actual results.
Key Highlights
- 1WellPoint reaffirmed its full-year 2013 diluted net income per share guidance of at least $8.45.
- 2The company expects adjusted net income per diluted share for full-year 2013 to be at least $8.40.
- 3Guidance excludes investment gains or losses beyond those recorded in the first nine months of 2013.
- 4Key adjustments impacting net income include realized investment gains/losses, impairment losses, debt extinguishment, tax benefits, and acquisition costs.
- 5A net of $0.05 per share is expected to be subtracted from reported net income to arrive at adjusted net income.
- 6The filing includes a standard safe harbor statement for forward-looking information.
- 7The report was filed by WellPoint, Inc., the registrant at the time.